- 2018: “Hologene 7 as a model for the development of an advanced therapy based on genetically corrected stem cells”, funded by Debra Südtirol-Alto Adige 5×1000, PI Prof. Michele De Luca - 2014: “Hologene 7 as a model for the development of an advanced therapy based on genetically corrected stem cells”, funded by Emilia-Romagna PI Michele De Luca (POR- FESR-2014-2020 CUP E92I16000220005) - 2013: “Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector – GENEGRAFT funded by European Union (FP7-HEALTH-2010 n. 261392), PI Michele De Luca - 2013: “Italian Regenerative Medicine Infrastructure (IRMI),一个旨在开发器官和组织再生的先进疗法的多区域基础设施”,由 MIUR PI Michele De Luca 资助(项目编号 CTN01_00177_888744)- 2013 年:“大疱性表皮松解症的基因治疗:从临床前到临床”,由 Fondazione Cassa di Risparmio di Modena 资助,PI Michele De Luca - 2010 年:“再生医学中心 - Tecnopolo di Modena”,由艾米利亚-罗马涅大区和欧盟资助,PI Michele De Luca (Axis 1 POR FESR 2007-2013)。
主要关键词